Glutamine and leukemia research: progress and clinical prospects

Area of Science:

• Biochemistry
• Oncology
• Hematology

Background:

• Leukemia involves abnormal white blood cell proliferation.
• Glutamine (GLN) is a crucial nutrient supporting leukemic cell growth and survival.
• Dysregulated differentiation, uncontrolled growth, and inhibited apoptosis characterize leukemia.

Purpose of the Study:

• To review recent advances in glutamine metabolism in leukemia.
• To explore the role of GLN metabolism in diagnosing and treating various leukemia subtypes.
• To highlight the potential of targeting GLN metabolism for effective leukemia therapy, particularly acute myeloid leukemia.

Main Methods:

• Literature review of studies on glutamine metabolism in leukemia.
• Analysis of GLN uptake and related indexes in leukemia patients.
• Examination of therapeutic strategies targeting GLN metabolism.

Main Results:

• GLN uptake and metabolic changes correlate with leukemia progression, remission, and relapse.
• Differences in GLN metabolism may aid in differentiating leukemia subtypes.
• Targeting GLN metabolism presents a promising therapeutic avenue, requiring simultaneous pathway blockade.

Conclusions:

• Glutamine metabolism is a critical factor in leukemia pathogenesis.
• Monitoring GLN-related indexes can assist in leukemia diagnosis and management.
• Targeting glutamine metabolism offers potential for novel leukemia treatments, with a focus on acute myeloid leukemia.